outbreak influenza hn metres first tandem st century transmit million individual claim live current status mani country prepare vaccine use cells eggs kill howe trait platform sever limit overcome research tri various approach develop alter product one approach report efficacy ha vaccine baculovir dna achervha immune response elicit target antigen lower commerce previous construct human endowed retroviru her envelope baculovirusbas viruslikeparticl vlpform term achervvlp california phn basic mouse immune ffu im compare result immune product greater humor exhibit neutral active intrasubgroup h strain pr antibody high level interferonÎ³ secret splenocyt diminish virus shed lung challenge lethal dose concur baculoviru could potent candid capable office deli vaccine lp form elicit stronger immunogen vaccine 